(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
5 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 15.42%
11.71% $ 0.727
Live Chart Being Loaded With Signals
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States...
Stats | |
---|---|
Dzisiejszy wolumen | 129 518 |
Średni wolumen | 5.50M |
Kapitalizacja rynkowa | 12.69M |
EPS | $0 ( 2024-03-28 ) |
Następna data zysków | ( $-0.170 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.190 |
ATR14 | $0.00900 (1.20%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-31 | Cittadine Andrew | Sell | 8 952 | Restricted Stock Units |
2024-03-31 | Cittadine Andrew | Buy | 8 952 | Common Stock |
2024-03-31 | Cittadine Andrew | Sell | 3 098 | Common Stock |
2024-03-31 | Tsuchimoto Kim R | Sell | 9 956 | Restricted Stock Units |
2024-03-31 | Tsuchimoto Kim R | Buy | 9 956 | Common Stock |
INSIDER POWER |
---|
36.92 |
Last 100 transactions |
Buy: 1 127 208 | Sell: 341 037 |
Wolumen Korelacja
Monopar Therapeutics Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
LRMR | 0.907 |
NAKD | 0.856 |
SGMO | 0.85 |
CFLT | 0.849 |
HCSG | 0.827 |
EQ | 0.823 |
TUEM | 0.819 |
CSII | 0.819 |
MEDP | 0.815 |
SRRA | 0.814 |
10 Najbardziej negatywne korelacje | |
---|---|
BLKB | -0.827 |
LIZI | -0.825 |
LMPX | -0.825 |
SSRM | -0.81 |
SGLB | -0.809 |
EGAN | -0.806 |
RMRM | -0.801 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Monopar Therapeutics Inc Korelacja - Waluta/Towar
Monopar Therapeutics Inc Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-0.610 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-0.610 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-0.830 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.730 |
Financial Reports:
No articles found.
Monopar Therapeutics Inc
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. Its lead product candidate in development is Validive, a clonidine hydrochloride mucobuccal tablet that is in Phase 2b/3 clinical trial for the prevention of chemoradiotherapy induced severe oral mucositis in patients with oropharyngeal cancer. The company also engages in developing Camsirubicin, an analog of doxorubicin, which is in Phase 1b clinical trial for the treatment of advanced soft tissue sarcoma; MNPR-101, a urokinase plasminogen activator receptor targeted antibody for the treatment of various cancers; MNPR-101 RIT, a radioimmunotherapeutic based on MNPR-101 for the potential treatment of cancer and severe COVID-19; and MNPR-202, an analog of camsirubicin to potentially treat doxorubicin-and camsirubicin-resistant cancers. Monopar Therapeutics Inc. has collaborations with the Grupo Español de Investigación en Sarcomas for the development of camsirubicin in patients with advanced soft tissue sarcoma; NorthStar Medical Radioisotopes, LLC to develop radio-immuno-therapeutics targeting severe COVID-19; and the Cancer Science Institute of Singapore to evaluate the activity of MNPR-202 and related analogs in various types of cancer. The company was incorporated in 2014 and is headquartered in Wilmette, Illinois.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej